2018
DOI: 10.1016/j.tranon.2018.03.003
|View full text |Cite
|
Sign up to set email alerts
|

Identification of Prognostic Biomarkers by Combined mRNA and miRNA Expression Microarray Analysis in Pancreatic Cancer

Abstract: Pancreatic cancer is the fourth leading cause for cancer-related death, and early diagnosis is one key to improve the survival rate of this disease. Molecular biomarkers are an important method for diagnostic use in pancreatic cancer. We used data from three mRNA microarray datasets and a microRNA dataset (GSE16515, GSE15471, GSE28735, and GSE41372) to identify potential key genes. Differentially expressed genes (DEGs) and microRNAs (DEMs) were identified. Functional, pathway enrichment, and protein-protein in… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
28
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 42 publications
(29 citation statements)
references
References 59 publications
(63 reference statements)
0
28
0
Order By: Relevance
“…MiRNAs can be used as biological markers for PCs [4,30], and PC is becoming a common malignant disease with an incidence that has continued to rise during the last few years [30,31]. Hence, specific biomarkers for accurate diagnostic tests and potential therapeutic targets for individualized therapy are yet to be fully determined in PDAC.…”
Section: Discussionmentioning
confidence: 99%
“…MiRNAs can be used as biological markers for PCs [4,30], and PC is becoming a common malignant disease with an incidence that has continued to rise during the last few years [30,31]. Hence, specific biomarkers for accurate diagnostic tests and potential therapeutic targets for individualized therapy are yet to be fully determined in PDAC.…”
Section: Discussionmentioning
confidence: 99%
“…miRNAs serve roles in numerous physiological and pathological processes including apoptosis, the cell cycle, cellular growth, proliferation, differentiation, metabolism and aging (6). Accumulating evidence reveals that miRNA dysfunction influences the metastasis, chemo-radioresistance and overall survival time of patients with cancer, including patients with PDAC (7)(8)(9)(10). Previous reports have revealed miRNA involvement in PDAC progression, including roles of miR-216b (11), miR-10a-5p (10), miR-374b-5p (12), miR-1271 (13), miR-7-5p (14), miR-4295 (15) and miR-185 (16).…”
Section: Introductionmentioning
confidence: 99%
“…In order to identify the miRNA(s), we have mined miRNAs with/for two criteria: (a) miRNA known to be secreted by CD4+ T cells and (b) miRNA known to affect differentiation of CD34+ stem cells in particular through the common myeloid progenitor into the megakaryocytic and erythrocytic lineages.…”
Section: Resultsmentioning
confidence: 99%